Intensified Secondary Prevention Intending a Reduction of Recurrent Events in TIA and Minor Stroke Patients

NACompletedINTERVENTIONAL
Enrollment

2,082

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2018

Study Completion Date

May 31, 2019

Conditions
Mini-Stroke
Interventions
BEHAVIORAL

Patient centered structured support program

"Behavioural: Structured support program~Program with up to 8 outpatient appointments focusing on:~* Measurement of risk factors~* Assessment of medication intake~* Monitoring of antithrombotic therapy~* Joint agreement of an individual target plan~Target values for risk factors:~* Blood pressure \< 140/85 mmHg (\<130/80 in diabetics), normal circadian profile~* HbA1c \<7.5%~* Nicotine abstinence~* LDL \< 100mg/dl (\< 70mg/dl in high risk patients)~* Physical activity ≥ 30min \>2 x / week~Targets for pharmaceutical treatment:~* Platelet inhibitors for strokes / TIA of arterial etiology~* Combined platelet inhibition over 3 months in symptomatic intra- or extracranial stenosis~* Cumarins (INR 2-3) or new oral anticoagulants in AF patients~* Statin treatment in patients with LDL \>100mg/dl~Intervention strategies:~• According to Motivational Interviewing"

Trial Locations (1)

12200

Dept. of Neurology, Charité Universitätsmedizin Berlin, Berlin

All Listed Sponsors
collaborator

Technical University of Munich

OTHER

collaborator

University of Erlangen-Nürnberg Medical School

OTHER

collaborator

Praxis für Neurologie und Psychiatrie am Prinzregentenplatz, München

UNKNOWN

collaborator

Technische Universität Berlin

OTHER

collaborator

Aarhus University Hospital

OTHER

collaborator

Klinikum Ludwigshafen

OTHER

collaborator

Vivantes Auguste-Viktoria-Klinikum

UNKNOWN

collaborator

Vivantes Clinic Neukölln

OTHER

lead

Charite University, Berlin, Germany

OTHER

NCT01586702 - Intensified Secondary Prevention Intending a Reduction of Recurrent Events in TIA and Minor Stroke Patients | Biotech Hunter | Biotech Hunter